CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program StudyShimin Hu, Ken H. Young, Eric D. Hsi et al.|Blood|2013Cited by 246
A phase 3 study of rituximab biosimilar HLX01 in patients with diffuse large B-cell lymphomaYuankai Shi, Xin Zhang, Yongping Song et al.|Journal of Hematology & Oncology|2020Cited by 50
Recurrent GNAQ mutation encoding T96S in natural killer/T cell lymphomaZhaoming Li, Mingzhi Zhang|Nature Communications|2019Cited by 34
<p>Anti-PD1 up-regulates PD-L1 expression and inhibits T-cell lymphoma progression: possible involvement of an IFN-&gamma;-associated JAK-STAT pathway</p>Weili Xue, Mingzhi Zhang|OncoTargets and Therapy|2019Cited by 31
ILs-3, 6 and 11 increase, but ILs-10 and 24 decrease stemness of human prostate cancer cells <i>in vitro</i>Dandan Yu, Zhenhe Suo, Yali Zhong et al.|Oncotarget|2015Cited by 24